Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.6%

1 terminated out of 62 trials

Success Rate

97.3%

+10.7% vs benchmark

Late-Stage Pipeline

15%

9 trials in Phase 3/4

Results Transparency

8%

3 of 36 completed with results

Key Signals

3 with results97% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (29)
P 1 (4)
P 2 (3)
P 3 (5)
P 4 (4)

Trial Status

Completed36
Unknown11
Recruiting8
Not Yet Recruiting3
Active Not Recruiting2
Terminated1

Trial Success Rate

97.3%

Benchmark: 86.6%

Based on 36 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT04613193Not ApplicableCompleted

Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis

NCT06205628Phase 1Active Not Recruiting

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

NCT07083765Phase 3Not Yet Recruiting

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

NCT06291207Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of AD-224

NCT06461273Not ApplicableCompleted

Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome

NCT05086523Phase 1CompletedPrimary

Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study

NCT04505618Not ApplicableRecruiting

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

NCT06501586Phase 1CompletedPrimary

Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

NCT07399912Not ApplicableEnrolling By InvitationPrimary

Engaging Home-monitored Assessment to Navigate Clinical Decision-making

NCT05546931Not ApplicableRecruitingPrimary

Mobile Health Program for Rural Hypertension

NCT05067998Recruiting

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

NCT05413057RecruitingPrimary

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

NCT03480217Not ApplicableCompletedPrimary

Implementing Hypertension Screening Guidelines in Primary Care

NCT03503773Phase 2Completed

The TARGET BP OFF-MED Trial

NCT06052748Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of AD-223

NCT03206814Not ApplicableRecruitingPrimary

Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System

NCT06718062Phase 4CompletedPrimary

Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia

NCT06019598Not ApplicableCompletedPrimary

Licorice and Home Blood Pressure, Additional Study

NCT05972785Active Not RecruitingPrimary

Long-term Use of CCB and Breast Cancer Risk

NCT06093932Phase 4RecruitingPrimary

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Scroll to load more

Research Network

Activity Timeline